# SURFAXIN
> **NDA021746** · New Drug Application · Sponsor: LEES PHARM HK · Approved 2012-03-06
## Drug
- **FDA Application Number:** NDA021746
- **Application type:** New Drug Application
- **Brand name:** SURFAXIN
- **Generic name:** Lucinactant
- **Active ingredients:** LUCINACTANT
- **Dosage form:** SUSPENSION
- **Route:** INTRATRACHEAL
- **Marketing status:** Discontinued
- **Sponsor:** LEES PHARM HK
- **First approval:** 2012-03-06
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021746)
---
*MORVS · CC0 1.0*